Connect Biopharma Holdings Limited (CNTB)
NASDAQ: CNTB · Real-Time Price · USD
2.020
-0.070 (-3.35%)
At close: Jul 31, 2026, 4:00 PM EDT
2.022
+0.002 (0.10%)
After-hours: Jul 31, 2026, 7:34 PM EDT
Connect Biopharma Holdings Employees
Connect Biopharma Holdings had 64 employees as of December 31, 2025. The number of employees increased by 2 or 3.23% compared to the previous year.
Employees
64
Change (1Y)
2
Growth (1Y)
3.23%
Revenue / Employee
$3,641
Profits / Employee
-$1,009,469
Market Cap
127.19M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 64 | 2 | 3.23% |
| Dec 31, 2024 | 62 | -19 | -23.46% |
| Dec 31, 2023 | 81 | -19 | -19.00% |
| Dec 31, 2022 | 100 | -8 | -7.41% |
| Jan 1, 2022 | 108 | 46 | 74.19% |
| Dec 31, 2020 | 62 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Nautilus Biotechnology | 127 |
| PepGen | 59 |
| Aardvark Therapeutics | 40 |
| Cue Biopharma | 29 |
| Genelux | 26 |
| TuHURA Biosciences | 22 |
| Canton Strategic Holdings | 12 |
CNTB News
- 19 days ago - Connect Biopharma Holdings Slides: Corporate presentation - Filings
- 24 days ago - Connect Biopharma initiated with an Outperform at Oppenheimer - TheFly
- 5 weeks ago - Connect Biopharma initiated with an Overweight at Piper Sandler - TheFly
- 6 weeks ago - Connect Biopharma Announces Completion of Enrollment of Phase 2 Seabreeze STAT Asthma Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in Asthma - GlobeNewsWire
- 2 months ago - Connect Biopharma initiated with a Buy at Canaccord - TheFly
- 2 months ago - Connect Biopharma initiated with an Overweight at Cantor Fitzgerald - TheFly
- 2 months ago - Connect Biopharma initiated with an Overweight at Cantor Fitzgerald - TheFly
- 2 months ago - Connect Biopharma Holdings Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts